Abbott Laboratories (ABT) Stock Analysis

HOLD

ABT Equity Research — HOLD — May 2026

Rating date

May 29, 2026

73 days ago

Desk view

HOLD

5D move

Neutral (HOLD unscored)

Peer rank

22p

Investment card · ABT

1. Sharp downtrend with a potential bottom: ABT lost >35% from mid-2025 to early May 2026. The $82.56 low on 11 May 2026 may be a short-term floor, but confirmation requires a sustained hold above the 20-day SMA.

Desk rating

HOLD

Tactical HOLD · 12M HOLD

Horizon

Long-term

Confidence

Medium

Invalidation

Thesis weakens if catalysts slip or risk markers breach stated levels.

Bias

HOLD

Catalysts

  • Sharp downtrend with a potential bottom: ABT lost >35% from mid-2025 to early May 2026. The $82.56 low on 11 May 2026 may be a short-term floor, but confirmation requires a sustained hold above the 20-day SMA.
  • Momentum is waking up: RSI has left oversold territory, and the MACD histogram turned positive for the first time since the decline began—early signs of bullish momentum building.
  • Volatility is still elevated but declining: The ATR has fallen from its peak but remains high. Wide intraday swings are still likely, making risk management critical.

Risks

  • Event-driven repricing risk if expectations diverge from incoming evidence.

Market chart

Price context alongside the research narrative.

ABT Research Note

Full desk note for May 29, 2026. Use tabs for catalysts, valuation and risks, or open the full note.

40 min read

WebserviceX · Agentic Research Desk

ABT Equity Research Note

Published May 29, 2026 · Desk view HOLD · Generated 2026-05-30T08:56:35Z · Maintained by Walter Vijayakumar · Methodology · Track record

ABT Stock Rating Summary

ABT bias

HOLD

Horizon

Long-term

ABT key risk

Event-driven repricing risk if expectations diverge from incoming evidence.

ABT catalyst watch

Sharp downtrend with a potential bottom: ABT lost >35% from mid-2025 to early May 2026. The $82.56 low on 11 May 2026 may be a short-term floor, but confirmation requires a sustained hold above the 20-day SMA.

Invalidation

Thesis weakens if catalysts slip or risk markers breach stated levels.

Confidence

Medium

How the call aged · 5D

Neutral (HOLD unscored)Peer 22p
Expand

Grading rule: BUY/OVERWEIGHT scores Correct when forward return > 0; UNDERWEIGHT/SELL when < 0; HOLD is Neutral. Window uses 5 US trading sessions after the rating entry close vs benchmark SPY. Scorecard computed 2026-05-30T11:24:08.729883+00:00.

5D move

2026-05-29 → awaiting

Outcome

Neutral (HOLD unscored)

5D trend

-2.47%

Vol (20D ann.)

+25.01%

vs SPY: -4.33%

Close 85.6 (USD, vendor closes)

Batch scorecard · 2026-05-29 · ABT